Kathleen Goetz
Directeur/Membre du Conseil chez ABRDN HEALTHCARE INVESTORS
Fortune : 66 162 $ au 30/04/2024
Profil
Kathleen L.
Goetz is an Independent Trustee and Trustee for several abrdn funds, including abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn World Healthcare Fund, and abrdn Healthcare Opportunities Fund.
She held the position of Vice President & Head-Sales at Novartis Pharmaceuticals Corp.
from 2017 to 2019.
Goetz received an undergraduate degree from Iowa State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/04/2024 | 1 148 ( 0,00% ) | 22 030 $ | 30/04/2024 | |
| 09/04/2024 | 1 079 ( 0,00% ) | 17 318 $ | 30/04/2024 | |
| 09/04/2024 | 1 085 ( 0,00% ) | 14 051 $ | 30/04/2024 | |
| 09/04/2024 | 1 017 ( 0,00% ) | 12 763 $ | 30/04/2024 |
Postes actifs de Kathleen Goetz
| Sociétés | Poste | Début |
|---|---|---|
| ABRDN HEALTHCARE INVESTORS | Directeur/Membre du Conseil | 01/01/2021 |
| ABRDN LIFE SCIENCES INVESTORS | Directeur/Membre du Conseil | 01/01/2021 |
| ABRDN WORLD HEALTHCARE FUND | Directeur/Membre du Conseil | 01/01/2021 |
| ABRDN HEALTHCARE OPPORTUNITIES FUND | Directeur/Membre du Conseil | 09/12/2021 |
Anciens postes connus de Kathleen Goetz
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/01/2016 |
Formation de Kathleen Goetz
| Iowa State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
abrdn Healthcare Investors
 abrdn Healthcare Investors Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA. | Miscellaneous |
abrdn Life Sciences Investors
 abrdn Life Sciences Investors Investment Trusts/Mutual FundsMiscellaneous abrdn Healthcare Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA. | Miscellaneous |
abrdn World Healthcare Fund
 abrdn World Healthcare Fund Investment Trusts/Mutual FundsMiscellaneous Tekla World Healthcare Fund is a closed-end management investment company, which engages in investing in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities and debt securities. The company was founded on March 5, 2015 and is headquartered in Boston, MA. | Miscellaneous |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
abrdn Healthcare Opportunities Fund
 abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Opportunities Fund operates as a closed-end investment fund and investment trust. The trust's investment objective is to seek current income and long-term capital appreciation through investing in companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Trust was founded on April 2, 2014 and is headquartered in Boston, MA. | Miscellaneous |
